REPRIEVE 60 BY REGENESIS Trademark

Trademark Overview


On Tuesday, March 19, 2024, a trademark application was filed for REPRIEVE 60 BY REGENESIS with the United States Patent and Trademark Office. The USPTO has given the REPRIEVE 60 BY REGENESIS trademark a serial number of 98457470. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, March 19, 2024. This trademark is owned by Regenesis Biomedical, Inc.. The REPRIEVE 60 BY REGENESIS trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for inducing cell proliferation, stimulating angiogenesis, soft tissue regeneration, tissue repair and regeneration, wound healing, and pain abatement
reprieve 60 by regenesis

General Information


Serial Number98457470
Word MarkREPRIEVE 60 BY REGENESIS
Filing DateTuesday, March 19, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateTuesday, March 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices for inducing cell proliferation, stimulating angiogenesis, soft tissue regeneration, tissue repair and regeneration, wound healing, and pain abatement

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2024
Primary Code010
First Use Anywhere DateMonday, December 18, 2023
First Use In Commerce DateMonday, December 18, 2023

Trademark Owner History


Party NameRegenesis Biomedical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85250

Trademark Events


Event DateEvent Description
Tuesday, March 19, 2024NEW APPLICATION ENTERED